Lonza Biologics PLC
Records under this name other than the patents Lonza Biologics PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,077,578 | Compositions and Methods for Treating Synucleinopathies Formerly held In force · High confidence | In force | High confidence | |
| US 12,351,624 | Compositions and Methods for Treating Synucleinopathies Formerly held In force · High confidence | In force | High confidence | |
| US 12,358,974 | Compositions and Methods for Treating Synucleinopathies Formerly held In force · High confidence | In force | High confidence | |
| US 12,358,975 | Compositions and Methods for Treating Synucleinopathies Formerly held In force · Low confidence | In force | Low confidence | |
| US 7,702,465 | Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom Term ended Term ended Nov 6, 2026 · USPTO record | Term ended | Term ended Nov 6, 2026 | USPTO record |
| US D664,262 | Impeller arrangement for fermenter Term ended Term ended Jul 24, 2026 · USPTO record | Term ended | Term ended Jul 24, 2026 | USPTO record |
| US 10,669,541 | Means and methods for the generation of mammalian producer cells for the production of recombinant proteins Lapsed on the fee record Ended Jun 2, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 2, 2024 | USPTO record |
| US 7,932,087 | Method of expressing recombinant protein in CHO cells Term ended Term ended Mar 7, 2024 · USPTO record | Term ended | Term ended Mar 7, 2024 | USPTO record |
| US 7,847,071 | Antibody Purification by Protein a and Ion Exchange Chromatography Term ended Term ended Mar 1, 2024 · High confidence | Term ended | Term ended Mar 1, 2024 | High confidence |
| US 8,338,177 | Cell culture medium Term ended Term ended Dec 7, 2023 · USPTO record | Term ended | Term ended Dec 7, 2023 | USPTO record |